AJP - Endo AJP citation statistics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab (May 9, 2006). doi:10.1152/ajpendo.00124.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/3/E429    most recent
00124.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davey, R. A
Right arrow Articles by MacLean, H. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davey, R. A
Right arrow Articles by MacLean, H. E
Submitted on March 15, 2006
Accepted on May 4, 2006

Current and Future Approaches Using Genetically Modified Mice in Endocrine Research

Rachel A Davey1 and Helen E MacLean1*

1 Department of Medicine (AH/NH), University of Melbourne, Heidelberg, Victoria, Australia

* To whom correspondence should be addressed. E-mail: hmaclean{at}unimelb.edu.au.

Genetically modified mouse models have been used widely to advance our knowledge in the field of endocrinology and metabolism. A number of different approaches to generate genetically modified mice are now available, which provide the power to analyze the role of individual proteins in vivo. However, there are a number of points to be considered in the use and interpretation of these models. This review will discuss the advantages and disadvantages involved in the generation and use of different genetically modified mouse models in endocrine research, including conventional techniques (e.g. over-expression, knockout and knock-in models), tissue and/or time specific deletion of target genes (e.g. Cre-loxP and siRNA transgenic approaches), and gene-trap approaches to undertake functional genomics. This review also highlights the many factors that should be considered when assessing the phenotype of these mouse models, many of which are relevant to all murine physiological studies. These approaches are a powerful means by which to dissect the function of genes, and are revolutionizing our understanding of endocrine physiology and metabolism.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. Asarian
Loss of cholecystokinin and glucagon-like peptide-1-induced satiation in mice lacking serotonin 2C receptors
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2009; 296(1): R51 - R56.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
H. E. MacLean, W. S. M. Chiu, C. Ma, J. F. McManus, R. A. Davey, R. Cameron, A. J. Notini, and J. D. Zajac
A floxed allele of the androgen receptor gene causes hyperandrogenization in male mice
Physiol Genomics, October 8, 2008; 33(1): 133 - 137.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
G. Matute-Bello, C. W. Frevert, and T. R. Martin
Animal models of acute lung injury
Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L379 - L399.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
H. E. MacLean, W. S. M. Chiu, A. J. Notini, A.-M. Axell, R. A. Davey, J. F. McManus, C. Ma, D. R. Plant, G. S. Lynch, and J. D. Zajac
Impaired skeletal muscle development and function in male, but not female, genomic androgen receptor knockout mice
FASEB J, August 1, 2008; 22(8): 2676 - 2689.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. T. Madsen
Recent Advances in SPECT Imaging
J. Nucl. Med., April 1, 2007; 48(4): 661 - 673.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.